Advertisement
Canada markets open in 7 hours 8 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7308
    +0.0010 (+0.14%)
     

  • CRUDE OIL

    82.97
    +0.16 (+0.19%)
     

  • Bitcoin CAD

    88,008.77
    -3,138.12 (-3.44%)
     

  • CMC Crypto 200

    1,389.68
    +7.10 (+0.51%)
     

  • GOLD FUTURES

    2,331.10
    -7.30 (-0.31%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,430.50
    -234.00 (-1.32%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6815
    -0.0004 (-0.06%)
     

Company News For Aug 9, 2019

Zacks Equity Research

  • Cardinal Health, Inc.’s CAH shares gained 2.7% after the company reported fourth quarter fiscal 2019 earnings per share of $1.11, higher than the Zacks Consensus Estimate of $0.93

  • Kontoor Brands, Inc.’s KTB shares gained 14.3% after the company reported second quarter 2019 earnings per share of $0.96, higher than the Zacks Consensus Estimate of $0.68

  • Shares of Norwegian Cruise Line Holdings Ltd. NCLH gained 2% after the company reported second quarter 2019 earnings per share of $1.30, higher than the Zacks Consensus Estimate of $1.26

  • Shares of Viacom Inc. VIAB rose 3.7% afterthe company reported third quarter fiscal 2019 earnings per share of $1.20, higher than the Zacks Consensus Estimate of $1.06


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Viacom Inc. (VIAB) : Free Stock Analysis Report
 
Norwegian Cruise Line Holdings Ltd. (NCLH) : Free Stock Analysis Report
 
Cardinal Health, Inc. (CAH) : Free Stock Analysis Report
 
Kontoor Brands, Inc. (KTB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research